Participated · Equity · Jul 2026

Nuclear Turbines aims to reduce the cost of nuclear power by replacing traditional steam turbine systems with highly efficient high-temperature turbine technology typically used in jet engines and gas-fired power plants, combined with a novel nuclear reactor design. Its compact systems are intended to be deployable "behind the meter" at industrial sites, data centres and manufacturing facilities. The company says this approach can lower generation costs to around one-fifth of today’s nuclear plants and builds on advancements in small modular reactors to address cost and scale challenges. Founded in 2025 and spun out of BAE Systems in partnership with Empirical Ventures' venture studio, the startup is led by Jeremy Owston and Professor Tim Abram. Following a £15m funding round led by IQ Capital, the company plans to use the capital for design, constructing large-scale test rigs and hiring to expand the team. No revenue, user or valuation metrics were disclosed in the articles.

Led · Equity · Jun 2026

Neuronostics develops BioEP, a clinically validated digital biomarker platform that analyses standard EEG recordings using eight predefined computational biomarkers and produces a report in under five minutes. The platform is UKCA-marked and ISO-13485 certified and has been validated across 15 NHS sites with over 1,000 recordings. NHS service evaluations are underway at multiple Trusts, including The Royal Wolverhampton NHS Trust and University Hospitals Dorset, and the company has a strategic partnership with Stratus to support scalable US deployment. Neuronostics plans to pursue FDA clearance (with a submission planned for 2026) and to extend the platform to provide brain fingerprints of treatment response in pharmaceutical trials. The company highlights clinical needs such as long diagnostic wait times, high misdiagnosis rates, and the high rate of inconclusive routine EEGs as drivers for its adoption.

Participated · Equity · Jun 2026

Silveray designs and manufactures flexible, ultra-thin X-ray film intended to make imaging sharper, less rigid and more comfortable. Its technology is used in industrial radiography—such as testing pipe integrity in oil and gas and detecting faults in aerospace and automotive components. The company is expanding into healthcare, targeting uses including more accessible, portable and affordable X-ray scans, breast cancer screening, radiotherapy and dental imaging. Silveray plans to scale up production and commercial relationships supported by the £5m raise. The firm intends to grow its team by 50% over the next two years to support this expansion.

Led · Equity · May 2026

Caudal Energy designs an oscillating foil "Caudal Generator" inspired by marine mammal tail fin hydrodynamics to harvest predictable tidal power using a modular, surface-mounted architecture. Its fin-based platform is engineered to operate efficiently in mid-flow tidal locations (peak flows above 3 knots), expanding the range of viable sites compared with conventional turbine systems that require higher peak flows. The modular design aims to simplify installation, lower maintenance and operational complexity, and reduce levelized cost of energy to be competitive with established technologies such as offshore wind. The technology has reached Technology Readiness Level 5 and is entering full-scale testing at Strangford Lough, with a targeted first commercial deployment in 2028 to reach TRL8. Caudal was founded in 2024 (originally Porpoise Power) based on breakthrough hydrodynamic research from the University of Oxford and is advancing commercial partnerships across utility, industrial and distributed energy markets.

Participated · Seed · Apr 2026

Fermtech develops a sustainable cocoa powder alternative produced from agricultural crop waste. The company positions its product as a response to rising chocolate prices driven by climate change. Fermtech has announced plans to scale production and roll out the product more widely following its recent seed raise. The business secured £2.5m in seed funding to expand manufacturing capacity. Available reporting does not disclose revenue, users, founding year, or valuation. The company is based in Oxford.